| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERS.12.1 |
| P698 | PubMed publication ID | 22283583 |
| P2093 | author name string | Andrew McIvor | |
| Naomi Spitale | |||
| Nooreen Popat | |||
| P2860 | cites work | Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial | Q24655820 |
| Exhaled nitric oxide measurements: clinical application and interpretation | Q24678480 | ||
| Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma | Q24678771 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Increased nitric oxide in exhaled air after intake of a nitrate-rich meal | Q32058611 | ||
| Exhaled nitric oxide in diagnosis and management of respiratory diseases | Q33568617 | ||
| Nitric oxide and asthma: a review | Q33802203 | ||
| Modelling the production of nitric oxide within the human airways | Q34058335 | ||
| ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
| Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans | Q34600899 | ||
| Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children | Q34619820 | ||
| The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial | Q34627601 | ||
| Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide | Q35532597 | ||
| Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease | Q35533230 | ||
| Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma | Q35533681 | ||
| An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications | Q35534747 | ||
| Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission | Q35537520 | ||
| Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding | Q35563652 | ||
| Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 | ||
| Nitric oxide in health and disease of the respiratory system | Q35842979 | ||
| Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study | Q36118636 | ||
| Nitric oxide in cystic fibrosis | Q36176840 | ||
| Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation | Q36545300 | ||
| Exhaled nitric oxide | Q36998167 | ||
| Pulmonary hypertension: evaluation and management | Q37001188 | ||
| Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells | Q37387553 | ||
| Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies | Q37406315 | ||
| Fractional exhaled nitric oxide in asthma: an update | Q37598970 | ||
| Exhaled nitric oxide in pulmonary diseases: a comprehensive review. | Q37786111 | ||
| Non-invasive assessment of exhaled biomarkers in lung transplantation | Q37866004 | ||
| Usefulness of Exhaled Nitric Oxide to Guide Risk Stratification for Bronchiolitis Obliterans Syndrome After Lung Transplantation | Q39815769 | ||
| Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics | Q40315613 | ||
| Salivary contribution to exhaled nitric oxide | Q40822469 | ||
| Nitric oxide in exhaled air. | Q41289379 | ||
| Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. | Q41537656 | ||
| Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance | Q42025418 | ||
| Expired nitric oxide levels during treatment of acute asthma | Q42061224 | ||
| Exhaled nitric oxide in stable chronic obstructive pulmonary disease | Q42141343 | ||
| Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis | Q42421460 | ||
| Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis | Q42818059 | ||
| Usefulness of exhaled nitric oxide for diagnosing asthma | Q42934151 | ||
| Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease | Q43061300 | ||
| Exhaled nitric oxide levels in asthma: Personal best versus reference values | Q43274046 | ||
| Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. | Q43297227 | ||
| Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 | ||
| Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children | Q43865637 | ||
| High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy | Q43916424 | ||
| Changes of exhaled nitric oxide during steroid treatment of childhood asthma | Q44056562 | ||
| Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship | Q44162549 | ||
| Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children | Q44162562 | ||
| Airway inflammation in premenstrual asthma | Q44176259 | ||
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
| Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma | Q44357077 | ||
| Chronic cough: eosinophilic bronchitis without asthma | Q44412316 | ||
| Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody | Q44827172 | ||
| A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. | Q45994046 | ||
| Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study | Q46174569 | ||
| Examining axial diffusion of nitric oxide in the lungs using heliox and breath hold | Q46232814 | ||
| Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma | Q46309541 | ||
| Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial | Q46565002 | ||
| Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. | Q46925786 | ||
| Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations | Q46968826 | ||
| The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. | Q47727199 | ||
| The relationship of exhaled nitric oxide to airway inflammation and responsiveness in children. | Q47760348 | ||
| Exhaled nitric oxide from lung periphery is increased in COPD. | Q47770379 | ||
| Novel hand-held device for exhaled nitric oxide-analysis in research and clinical applications | Q47779700 | ||
| Exhaled nitric oxide as a screening tool for asthma in school children | Q47799251 | ||
| The effect of spirometry and exercise on exhaled nitric oxide in asthmatic children | Q47807964 | ||
| Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children | Q47849250 | ||
| Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia | Q47911559 | ||
| NO pathway in CF and non-CF children | Q47948993 | ||
| The use of exhaled nitric oxide in the diagnosis of asthma in school children | Q48402544 | ||
| Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. | Q50697152 | ||
| Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. | Q50787410 | ||
| The effect of the menstrual cycle on exhaled nitric oxide and urinary nitrate concentration. | Q51008547 | ||
| Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. | Q51640103 | ||
| Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
| Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. | Q51680181 | ||
| Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. | Q51687788 | ||
| Exhaled Nitric Oxide after β2-agonist Inhalation and Spirometry in Asthma | Q58387541 | ||
| Exhaled Nitric Oxide in Human Lung Transplantation | Q58387550 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 105-115 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
| P1476 | title | Update on exhaled nitric oxide in pulmonary disease | |
| P478 | volume | 6 |
| Q42273619 | Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight--new perspectives? |
| Q26771615 | Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma |
| Q26772201 | Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma |
| Q28082277 | Clinical application of exhaled nitric oxide measurements in a korean population |
| Q38706709 | Diagnostic accuracy of fractional exhaled nitric oxide in asthma: a systematic review and meta-analysis of prospective studies |
| Q92100926 | Dual role of the L-arginine-ADMA-NO pathway in systemic hypoxic vasodilation and pulmonary hypoxic vasoconstriction |
| Q39025584 | Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review. |
| Q36823821 | Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function |
| Q40113039 | Nitrogen dioxide is genotoxic in urban concentrations |
| Q38025728 | Past, present and future uses of methacholine testing |
Search more.